FocusTuberculosis

For Whom the Bell Tolls: Isoniazid Preventive Therapy and Tuberculosis Drug Resistance

See allHide authors and affiliations

Science Translational Medicine  10 Apr 2013:
Vol. 5, Issue 180, pp. 180fs12
DOI: 10.1126/scitranslmed.3006094

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the “double use” of isoniazid for prophylaxis and curative treatment (Mills et al., this issue).

View Full Text